Cantor Fitzgerald Starts BioMed Realty (BMR) at Hold; Leasing Up Well But Risk Remains

February 6, 2012 4:50 PM EST
Get Alerts BMR Hot Sheet
Price: $1.32 +3.94%

Rating Summary:
    6 Buy, 8 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Cantor Fitzgerald initiates coverage on BioMed Realty (NYSE: BMR) with a Hold. PT $19.50.

Analyst, Sri Nagarajan, said, "Gradualism is an appropriate term to characterize U.S. lab space recovery, akin to slow evolution over time. While lab space fundamentals have improved significantly over the past 18-24 months, we expect that improvement will be only modest through 2012-14. We note that the company has been successful in filling vacant lease-up space, notably in East Bay, CA, and has addressed its capital availability/balance sheet issues through equity issuance and selective acquisitions."

For an analyst ratings summary and ratings history on BioMed Realty click here. For more ratings news on BioMed Realty click here.

Shares of BioMed Realty closed at $19.33 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Cantor Fitzgerald